We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Hellenic Dynamics Plc | HELD | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.25 | -11.63% | 1.90 | 11:13:41 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.15 | 1.70 | 2.15 | 1.90 | 2.15 |
| Industry Sector |
|---|
| EQUITY INVESTMENT INSTRUMENTS |
| Top Posts |
|---|
Posted at 05/5/2024 00:32 by institutional investments Problem is the overall market./ MSOS, MJ etcIf you break down the whole market, it is far from expecting the stupid 30% CAGR's by 2030 etc In the recent lifts, HELD was a company that the managers could have added. It fits. They didnt Held couldnt lift on a sector bear market retrace hardly going to do much now with s sector turning back |
Posted at 23/4/2024 18:30 by halland75 I have to add comedy, I can't begin to tell you how impressed with the loan terms and interest rate.15 years!!! Can you imagine the business plan, and perhaps recent positive developments that HELD have not yet disclosed to us, for that lender to offer such generous terms. There is much they would have had to prove...and they did so successfully. I reckon HELD are trying to equal or better those terms with Piraeus Bank. PB will be well aware of the funding/terms HELD have already achieved elsewhere. I now can't see PB refusing us. I think an offer is already in. I believe they are only wrangling over interest rates. IMO. 3million buy after close today. |
Posted at 17/4/2024 21:53 by masergt Re cultivation and numbers (from across the road):OAPK20 Today 16:14 Posts: 2,465 Price: 2.35 No Opinion Trying to get a handle on the numbers HELD are targeting. Full pelt they target 54000kg dried flowers per annum. They have a 40,000m2 active cultivation licence, in their 195,506 square metre facility located near Thessaloniki. Is the site with a facility set up for vertical cultivation or is it outdoor growing? The average yield per plant is 2oz (56.7g) of bud. So the 54000kg (1,904,794ounces) per year mark looks more aspirational at this time. They , depending on set up need 4 separate areas. Nursery stage, growing stage, flowering stage and drying area, for continual rotational cultivation. Then packing and dispatch areas on top Ave cycle (cutting to flower) is 14 weeks. So potentially 4 crops per year. A fully grown flowering plant is easily 0.5m2 of floor space (if they’re nettles) or 1m2 if decent. Depends how crammed in they will be. Given its medical grade there’ll be strict controls on nutrients etc. Even if they achieve 3-4ounces per plant average under controlled growing conditions to achieve medical grade the numbers and space currently under licence are tight. The following numbers are pretty big for the 40,000m2 licences area in my view. Unless it is set up for vertical cultivation. 80,000 plants (0.5m2) at eg. better case average of 3ounces per plant cropped and dried is 240,000ounces per crop. On a 12-14 week rotation say 4 crops per year is 960,000 ounces or 27215.5kg. So to hit their full target they need minimum 160,000 plants if they get an average of 3 ounces per plant. More likely 1-2 ounces so more plants in my view. The medical site (not connected to held) I have visited, used outdoor cultivation and yielded an average of 1-2 ounces of bud per plant over 16-18 week cycle. 3 crops on a 54 week cycle. Which is why I’m asking about the numbers HELD are targeting and type of facility they have ? |
Posted at 03/4/2024 16:28 by extrader This from investing Genius (sic) :If - per 4 - the bank (still Piraeus?) is a big supporter (a) why is there no update re status of the loan application and (b) why is there talk of alternative funding? If - per 5 - HELD only took GBP 350 K (we were told $450K, never mind) and has been repaying 'since October' why only announce a mix of P + I (no breakdown) PARTIAL repayment, 5 months later ? PS as I showed in an earlier post, it's arithmetically impossible for HELD to have been repaying instalments in full since October and still only have paid off principal (AND interest) of GBP 90K...which suggests that they're in some kind of 'soft default' / forbearance, surely? This from a man who acknowledges (point 13) that 'PR and comms haven't been good' .......and assures us that he's going to do better. That 'New year's resolution' hasn't worn well ! Point 6 acknowledges that HELD is indeed 'running on fumes'. If RGO is liquidating its portfolio as quickly as it can (per Halland75/Investing Genius), they're hardly likely to disincentivize early payment by imposing a penalty fee, are they? What's the betting HELD will nevertheless use that as a reason for drawing out repayments ? 'There are more questions than answers...and the more we find out, the less we know', it would seem. Same old, same old...AFAICS |
Posted at 30/3/2024 19:51 by extrader The HELD payment of £90,756 paid in shares on 28 March @ 1.26 = $ 114,352.We're told that this is 'part of an outstanding loan and accrued interest'. The question is (or should be): How big a 'part' ? It was paid 28 March 2024 on a loan for $450K taken out 26 October 2023 ie 5 months ago. .."The annual interest rate payable by the Company is 15% per annum payable on any outstanding amounts, quarterly in arrears. ยท Each advance is repayable in monthly cash instalments after a holiday period, expected to be serviced from operational cashflow over the next 12-months.." Unhelpfully (again) we're not told what the grace period is. The loan is $ 450 K. If HELD had paid in 12 instalments, that would be $ 37.5K per month or $187.5K due to date. This exceeds the repayment actually made and also rules out a grace period. A 1 or 2 month grace period would mean principal repayments of $163K (4 months@ $41K) or $135K (3 months @ $45K), so also not arithmetically possible. So let's try a 3 month grace period and 9 instalments of $50K. Two instalments due end March 2024 would be $ 100K. If interest is paid 'quarterly in arrears', after 5 months only 3 months interest is due. Three months' interest @ 15% on $450K would be ($67,500/12 *3 =) $16,875, together $ 116,875. Absent any 'hard info', this seems as good a working hypothesis as any. If so, HELD has paid off $100K out of its $450K loan and had accrued interest payable of $ 11,250 at end March 2024. The situation appears even tighter than my 'blink' impression on first read. If anyone has different numbers, pls share...including your assumptions ! GLA and ATB |
Posted at 25/3/2024 09:12 by oakridge nb. There has been a fresh fly by and image capture on Google Earth and interestingly, now that HELD's site in Greece is fully deaccessioned from its previous role with the U.N., pixilation is now no longer needed.Although there were some great images supplied in the Facility Update RNS, one can now see from Google just what a vast site HELD have, with much work on the ground in evidence. I believe the site, the license size and what HELD have managed to put into place thus far is worth well in excess of the market cap - particularly when compared to other players in the space. Execution of the plan, or an initial part of it however - and proving operational competence - is obviously key. There are some top growers in and around the company (with a proven track record of implementing large grow sites) which can only be a good thing. Hopefully the arrangement with Piraeus Bank with come to fruition and this can be the trigger many are looking for. Any such signs and I anticipate a significant market correction from these levels: the shares will simply be too cheap for the market to ignore. Fingers crossed and NAI etc etc and good luck. |
Posted at 25/3/2024 08:58 by oakridge Good morning folks.I've received a couple of messages from other HELD investors asking if I'm still interested in this company, so may as well answer on here. Yes, I remain fully invested and haven't sold any shares at all. I posted back in January in response to the last RNS and tend now only to post when there is something tangible to respond to. Since then I've actually doubled my holding and vastly improved my average, so I remain more than committed even if I accept the hitting of certain key operational targets has taken longer than I had anticipated. There remains a decent level of interest in the company within the investment community, however much of this enthusiasm appears to have shifted away from ADVFN, for now at least. There are of course uncertainties and HELD remains a speculative proposition, but there are some key aspects about HELD (all of which have been discussed on here before) that remain attractive and compelling for me and the outright size of the opportunity remains undiminished imo. As someone pointed out above, KNB are openly celebrating the recent regulatory developments in the German mkt. And that is just one market from many. I believe we have a dogged CEO working hard to position the company correctly and who has already proven, through a very lengthy listing process, that he has the best intentions. The company also has some highly prominent advisors who naturally would want only to be associated with a sincere and, ultimately successful, venture. The recent fall of the share price has, I believe, been in response to sustained selling, compounded with a gulf in news flow. However as others have pointed to, it could be that we are now approaching the thick end of the wedge and much of the waiting and suppressing activity within the market could be behind us. I hope so anyway. AIMO only so ADYOR and NAI etc. |
Posted at 27/1/2024 23:23 by halland75 Danielm89,If you are around at some point I would really like to know what you think of this, I ask you as you were the first who pieced together a possible Pfizer link with HELD. I think it's a very realistic possibility that Pfizer could buy HELD once IP protection is secured (see the NBC piece below where it states Pfizer abandoned its cannabis-related patents). And remember in an interview Davinder was not opposed to a buyout. If Pfizer partnered/bought HELD out, perhaps Pfizer now feels the time is right to continue the work they had discontinued in regards to their pain treatments. Remember that HELD can produce different strains of medicinal cannabis, and that if HELD secured that IP protection, meaning only they can be used to supply it. Covid is over, Greek Banking crisis is over, Large Pharmaceuticals getting into the medicinal cannabis space, and that Pfizer link.... "Big Pharma Watching, Waiting and Building Cannabis Patent Portfolio". Published on: July 10, 2019 David Hodes "Big pharma is working on locking up cannabis patents, creating partnerships, and standing by to use its financial muscle for more ownership of the medical cannabis industry when the time is right". This piece from NBC News Now on Sept. 26, 2019, 5:44 PM BST By Noah Smith A Pfizer spokesperson, Sally Beatty, said the company “abandoned&rdq Is it just wishful thinking from me, or perhaps everything is aligning now? At this IMO, right time. |
Posted at 17/1/2024 19:10 by extrader Guys,The Piraeus offer is highly conditional and short on substance. The facilities discussed are : (1) Export factoring = discount of receivables ie any payment risk on buyer, after HELD has jumped hoops on performance (production, quality etc); (2) APG's in respect of grants already applied for ie self-liquidating discount of receivables ie primary payment risk on grantor, not HELD (other than secondary recourse); (3) unquantified working capital for plant expansion (presumably above that plant already (?) commissioned). No detail re amounts of ££ involved, pricing or security terms. It also requires a detailed reworking/updating of HELD's business plan (the original IPO version presumably superseded by the recently acknowledged 'pivot' in business model), to be submitted by an independent third party consultant acceptable to Piraeus. Apart from the additional cost, that's not exactly a vote of confidence in HELD management, is it? Nor does it seem likely to be a quick process, IMO. A step forward, to be sure, but not quite as it's been bigged up to be, AFAICS. GLA |
Posted at 29/11/2023 18:28 by masergt Nothing like that gozo.#1958. Gross overstatement. I railed against the false dawns, the numerous missed final long stop dates, the misinformation and excuses given like PJ, a long experienced corporate lawyer and senior partner, failing to anticipate the need for pan EU jurisdictional approvals; like saying the prospectus had been submitted to the FCA when it hadn't; like missing all the numbers he RNS'd when acquiring HELD. I gave him credit when the RTO completed but guessed he'd be quickly selling down his c. 2.5m shares. #1959. N.B. Not "5 or 6 years now" gozo. My interest goes back only to February 2021 when Cathal Friel invested. MOGP closed in March 2021 creating SPC. The HELD acquisition was announced in August 2021 so you're another who bends the truth to make a point. The HELD Prospectus - when it arrived - was nothing like that promised by PJ prior to the suspension of UK SPAC plc. "IN BRIEF: UK SPAC to acquire Hellenic Dynamics for GBP45 million. Mon, 02nd Aug 2021 17:29 Alliance News UK SPAC PLC - cash shell formerly known as Mountfield Group - Shares in London suspended on entry of agreement to acquire European medicinal cannabis firm Hellenic Dynamics SA for GBP45.2 million in shares. Payment is to be satisfied by issue of up to 9.58 billion shares at a price of 0.472 pence per share at the minimum. Proposed acquisition is expected to value UK SPAC at a minimum of GBP11.8 million at the issue price. Deal is conditional on regulatory and shareholder approval at an upcoming general meeting, and the enlarged company being restored to trading on AIM before the long stop date of October 31. "I am delighted that the company has been able to contract to acquire this extremely exciting and impressive company which has the ambition and the potential to become one of the major growers of medicinal cannabis in Europe," says Chair Peter Jay. Current stock price: 0.21 pence Year-to-date change: down 60% By Dayo Laniyan; dayolaniyan@alliance Copyright 2021 Alliance News Limited. All Rights Reserved. Then eventually, 16 months later, we got: "Alliance News 15 November, 2022 | 3:51PM (Alliance News) - UK SPAC PLC announced on Tuesday its proposed reverse takeover of European medical cannabis cultivation company Hellenic Dynamics has been approved by the Financial Conduct Authority. The proposed acquisition by the London-based special purpose acquisition group entails the purchase of 10.4 billion of ordinary shares at a price of 0.3 pence each. This price was determined after it was agreed Hellenic Dynamic's market valuation had fallen to around GBP31.2 million. It was initially valued at GBP45.2 million on August 2, 2021, when the initial terms of the transaction were announced. UK SPAC is set to change its name to Hellenic Dynamics, with executives at Hellenic set to take charge. It has also proposed a subscription of 250 million new ordinary shares at 0.3 pence each to raise GBP750,000. A further GBP375,000 is planned to be raised through the issue of unsecured convertible loan notes, which can be converted at a price of 0.3 pence each. UK SPAC said it expects to raise GBP1.1 million from both the subscription and issue of loan notes, as part of its readmission to the London Stock Exchange. "With the announcement today of the first successful UK listing of a medical cannabis grower, all our efforts have been rewarded," said Peter Jay, UK SPAC chair. Hellenic Dynamics Chief Executive Officer Davinder Rai said he looked forward to transitioning into a public company. Kanabo Group PLC said on Tuesday it was delighted the FCA approved UK SPAC's proposal, after acquiring an interest of GBP750,000 worth of shares in Hellenic Dynamics on May 24. By Greg Rosenvinge; gregrosenvinge@allia Copyright 2022 Alliance News Limited. All Rights Reserved." Now compare those numbers: - Up to 9.58 billion shares @ 0.472p values SPC at minimum £11.8m, HELD @ £45.2m. What we got was: - 10.4b shares @ 0.30p + 250m subscription for £750,000. - Grants of 1.172b options + 375m warrants + other stuff taking shares to 12.53b. - 30% dilution straight away. - The above freebies shared out between 4 directors, 4 advisors and 6 managers! - Associated placing and CLN to raise £1.125m, share price tanked to 0.15p. - Alleged HELD valuation at relisting of £31.2m v. £45.2m. - Actual valuation a week or so later of c. £12m and share price of c. 0.10p. - Pre 100:1 consolidation share price of 0.045p. Current valuation of c. £6m. - Loss from 5th Dec '22 RNS to Dec '23, approx 84%. - Actual achievement? No crops, no harvests, no cash, death spiral finance. - And what's happened to Kanabo after agreeing to buy £750,000 of shares @ 0.30p? - Lol. Thing is gozo, those are the facts which fools try to deny and toss aside. Not my fault if they close their eyes and lose their bet, but then you can't educate pork. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
